182 related articles for article (PubMed ID: 21224292)
1. Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability.
Montecucco F; Vuilleumier N; Pagano S; Lenglet S; Bertolotto M; Braunersreuther V; Pelli G; Kovari E; Pane B; Spinella G; Pende A; Palombo D; Dallegri F; Mach F; Roux-Lombard P
Eur Heart J; 2011 Feb; 32(4):412-21. PubMed ID: 21224292
[TBL] [Abstract][Full Text] [Related]
2. Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis.
Pagano S; Carbone F; Burger F; Roth A; Bertolotto M; Pane B; Spinella G; Palombo D; Pende A; Dallegri F; Satta N; Virzi J; Fontana P; Mach F; Montecucco F; Vuilleumier N
Thromb Haemost; 2016 Aug; 116(3):554-64. PubMed ID: 27356567
[TBL] [Abstract][Full Text] [Related]
3. Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4.
Montecucco F; Braunersreuther V; Burger F; Lenglet S; Pelli G; Carbone F; Fraga-Silva R; Stergiopulos N; Monaco C; Mueller C; Pagano S; Dallegri F; Mach F; Vuilleumier N
Thromb Haemost; 2015 Aug; 114(2):410-22. PubMed ID: 25879306
[TBL] [Abstract][Full Text] [Related]
4. Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex.
Pagano S; Satta N; Werling D; Offord V; de Moerloose P; Charbonney E; Hochstrasser D; Roux-Lombard P; Vuilleumier N
J Intern Med; 2012 Oct; 272(4):344-57. PubMed ID: 22329401
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of anti-apolipoprotein/A-1 autoantibodies in maintenance hemodialysis and association with dialysis vintage.
Pruijm M; Schmidtko J; Aho A; Pagano S; Roux-Lombard P; Teta D; Burnier M; Vuilleumier N
Ther Apher Dial; 2012 Dec; 16(6):588-94. PubMed ID: 23190520
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy.
Vuilleumier N; Montecucco F; Spinella G; Pagano S; Bertolotto M; Pane B; Pende A; Galan K; Roux-Lombard P; Combescure C; Dallegri F; Mach F; Palombo D
Thromb Haemost; 2013 Apr; 109(4):706-15. PubMed ID: 23364307
[TBL] [Abstract][Full Text] [Related]
7. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
Vuilleumier N; Charbonney E; Fontao L; Alvarez M; Turck N; Sanchez JC; Burkhard PR; Mensi N; Righini M; Reber G; James R; Mach F; Chevrolet JC; Dayer JM; Frostegard J; Roux-Lombard P
Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
[TBL] [Abstract][Full Text] [Related]
8. Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis.
Vuilleumier N; Bas S; Pagano S; Montecucco F; Guerne PA; Finckh A; Lovis C; Mach F; Hochstrasser D; Roux-Lombard P; Gabay C
Arthritis Rheum; 2010 Sep; 62(9):2640-50. PubMed ID: 20506304
[TBL] [Abstract][Full Text] [Related]
9. Anti-apolipoprotein A-1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitis.
Wick PA; Mombelli A; Pagano S; Moren X; Giannopoulou C; Mach F; Roux-Lombard P; Vuilleumier N
J Periodontal Res; 2013 Jun; 48(3):350-6. PubMed ID: 23050768
[TBL] [Abstract][Full Text] [Related]
10. Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction.
Vuilleumier N; Rossier MF; Pagano S; Python M; Charbonney E; Nkoulou R; James R; Reber G; Mach F; Roux-Lombard P
Eur Heart J; 2010 Apr; 31(7):815-23. PubMed ID: 20176799
[TBL] [Abstract][Full Text] [Related]
11. Atherosclerotic plaque vulnerability is increased in mouse model of lupus.
Santiago-Raber ML; Montecucco F; Vuilleumier N; Miteva K; Baptista D; Carbone F; Pagano S; Roth A; Burger F; Mach F; Brandt KJ
Sci Rep; 2020 Oct; 10(1):18324. PubMed ID: 33110193
[TBL] [Abstract][Full Text] [Related]
12. Anti-Apolipoprotein A-1 IgG Influences Neutrophil Extracellular Trap Content at Distinct Regions of Human Carotid Plaques.
da Silva RF; Baptista D; Roth A; Miteva K; Burger F; Vuilleumier N; Carbone F; Montecucco F; Mach F; Brandt KJ
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33086507
[TBL] [Abstract][Full Text] [Related]
13. Anti-apoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity.
Vuilleumier N; Bratt J; Alizadeh R; Jogestrand T; Hafström I; Frostegård J
Scand J Rheumatol; 2010 Nov; 39(6):447-53. PubMed ID: 20604674
[TBL] [Abstract][Full Text] [Related]
14. Definition of human apolipoprotein A-I epitopes recognized by autoantibodies present in patients with cardiovascular diseases.
Teixeira PC; Ducret A; Ferber P; Gaertner H; Hartley O; Pagano S; Butterfield M; Langen H; Vuilleumier N; Cutler P
J Biol Chem; 2014 Oct; 289(41):28249-59. PubMed ID: 25170076
[TBL] [Abstract][Full Text] [Related]
15. Collagenase matrix metalloproteinase-8 expressed in atherosclerotic carotid plaques is associated with systemic cardiovascular outcome.
Peeters W; Moll FL; Vink A; van der Spek PJ; de Kleijn DP; de Vries JP; Verheijen JH; Newby AC; Pasterkamp G
Eur Heart J; 2011 Sep; 32(18):2314-25. PubMed ID: 21289041
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against apolipoprotein A-1 and phosphorylcholine for diagnosis of non-ST-segment elevation myocardial infarction.
Keller PF; Pagano S; Roux-Lombard P; Sigaud P; Rutschmann OT; Mach F; Hochstrasser D; Vuilleumier N
J Intern Med; 2012 May; 271(5):451-62. PubMed ID: 22061093
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice.
Nencioni A; da Silva RF; Fraga-Silva RA; Steffens S; Fabre M; Bauer I; Caffa I; Magnone M; Sociali G; Quercioli A; Pelli G; Lenglet S; Galan K; Burger F; Vázquez Calvo S; Bertolotto M; Bruzzone S; Ballestrero A; Patrone F; Dallegri F; Santos RA; Stergiopulos N; Mach F; Vuilleumier N; Montecucco F
Thromb Haemost; 2014 Feb; 111(2):308-22. PubMed ID: 24196571
[TBL] [Abstract][Full Text] [Related]
18. Basic fibroblast growth factor mediates carotid plaque instability through metalloproteinase-2 and -9 expression.
Sapienza P; di Marzo L; Borrelli V; Sterpetti AV; Mingoli A; Piagnerelli R; Cavallaro A
Eur J Vasc Endovasc Surg; 2004 Jul; 28(1):89-97. PubMed ID: 15177237
[TBL] [Abstract][Full Text] [Related]
19. Age-related changes in plaque composition: a study in patients suffering from carotid artery stenosis.
van Oostrom O; Velema E; Schoneveld AH; de Vries JP; de Bruin P; Seldenrijk CA; de Kleijn DP; Busser E; Moll FL; Verheijen JH; Virmani R; Pasterkamp G
Cardiovasc Pathol; 2005; 14(3):126-34. PubMed ID: 15914297
[TBL] [Abstract][Full Text] [Related]
20. The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques.
Montecucco F; Di Marzo V; da Silva RF; Vuilleumier N; Capettini L; Lenglet S; Pagano S; Piscitelli F; Quintao S; Bertolotto M; Pelli G; Galan K; Pilet L; Kuzmanovic K; Burger F; Pane B; Spinella G; Braunersreuther V; Gayet-Ageron A; Pende A; Viviani GL; Palombo D; Dallegri F; Roux-Lombard P; Santos RA; Stergiopulos N; Steffens S; Mach F
Eur Heart J; 2012 Apr; 33(7):846-56. PubMed ID: 22112961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
